The 20 Best Non-Hodgkin Lymphoma Doctors Near Me in Pittsburgh, PA

Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is rated as an Elite provider by MediFind in the treatment of Non-Hodgkin Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Kathleen Dorritie, MD, is a hematologist/medical oncologist at UPMC Hillman Cancer Center specializing in hematologic malignancies and stem cell transplantation. Her research focuses on early phase clinical trials for lymphoid malignancies. She has been very involved in the development of the CAR T-cell program at UPMC and has also worked to develop a stem cell transplant program for hemoglobinopathies, including sickle cell disease. Dr. Dorritie is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Annie Im, MD, is an Associate Professor of Medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing and conducting research in hematologic malignancies (such as acute leukemia), drug development, stem cell transplantation, and graft-versus-host-disease. In addition, Dr. Im leads the chronic graft-versus-host-disease and stem cell transplant survivorship clinic. Dr. Im is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. Her top areas of expertise are Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Aspiration, and Bone Marrow Transplant.

Jing-Zhou Hou, MD, PhD, is a clinical hematological oncologist specializing in hematological malignancies, cell therapy, and bone marrow transplant in the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center. Dr. Hou received his medical degree from Henan Medical University in China, his master’s degree at Shanghai Medical University, and his PhD in Molecular and Cell Biology from Tulane University. He completed his internal medicine residency in Northeastern Ohio University College of Medicine, and fellowship in Hematology and Oncology at Stanford University. He joined UPMC Hillman Cancer Center in 2007. Dr. Hou is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

James M. Rossetti, DO, is a hematologist specializing in the treatment of hematological malignancies and myeloid diseases, including myelodysplasia, acute myeloid leukemia, and myeloproliferative neoplasm. He also specializes in cellular therapy. Dr. Rossetti is a referral physician for the UPMC MDS Center of Excellence. Dr. Rossetti is rated as an Advanced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

Kelly G. Ross, MD, specializes in hematology oncology and is board-certified in hematolgoy and medical oncology by the American Board of Internal Medicine. She is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ross completed her fellowship at the University of Colorado and residency and medical degree at the University of Pittsburgh School of Medicine. Dr. Ross is rated as an Advanced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Robert VanderWeele, MD, MS, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in cytopenias, bleeding and clotting disorders, leukemia, lymphoma, myeloma, GI malignancies, breast cancer, lung cancer, and prostate cancer. Dr. Vanderweele is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.

Kiran Kumar Rajasenan, MD, is a medical oncologist at UPMC Hillman Cancer Center, Wexford. Board-certified in internal medicine and medical oncology, Dr. Rajasenan received his medical degree from Hahnemann Medical College, now Drexel University College of Medicine in Philadelphia. He completed his residency at Allegheny General Hospital in Pittsburgh. Dr. Rajasenan is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma.

Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma.

Dr. Kane has practiced for more than 20 years and is board certified in Medical Oncology. He received his medical degree from Ohio State University School of Medicine. He completed his residency training in Hematology/Oncology at the University of Pittsburgh School of Medicine. Dr. Kane is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Essential Thrombocythemia, Small Cell Lung Cancer (SCLC), and Familial Colorectal Cancer.

Melissa K. Yee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center.  She specializes in the treatment of solid tumors and blood disorders.Dr. Yee is board-certified by the American Board of Internal Medicine in medical oncology, hematology, and internal medicine.  She received her medical degree from the Drexel University College of Medicine in Philadelphia. She then completed her internal medicine residency and hematology/oncology fellowship at UPMC. She earned her undergraduate degree from Tufts University. After completion of her medical training, she was on staff at Dana Farber Cancer Institute in Boston before returning to Pittsburgh to practice at UPMC Mercy.Dr. Yee is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology, and Massachusetts Medical Society. Dr. Yee is rated as an Experienced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Shannon L. Puhalla, MD, is assistant professor of medicine at the University of Pittsburgh School of Medicine, and a medical oncologist and hematologist at UPMC Hillman Cancer Center. She specializes in breast oncology, Phase I clinical trials, and novel therapeutics in breast cancer. Dr. Puhalla is rated as an Experienced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Vikram C. Gorantla, MD, specializes in the treatment of sarcoma, breast cancer, gastrointestinal malignancies, and head and neck cancers. Board-certified in internal medicine and medical oncology, he received his medical degree at the University of Texas Southwestern Medical School in Dallas. He completed his internal medicine residency at Washington University, St. Louis, MO, and his hematology/oncology fellowship at UPMC.Dr. Gorantla has a dedicated day seeing breast cancer patients at the Magee-Womens Cancer Progam. He also collaborates with surgical oncologists and gynecologists/oncologists to provide multidisciplinary care to patients. Dr. Gorantla is rated as an Experienced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Endoscopy, and Gamma Knife Radiosurgery.

Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. Dr Smith specializes in bleeding and thrombotic disorders, Rare Homologic Diseases, Chronic Leukemia and Myelodyplasia.Dr. Smith is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from The Ohio State University, Columbus, and his Master of Science degree from the University of Wisconsin, College of Medicine, Madison. He completed his residency in medical oncology and his fellowship in hematology oncology, both at The Ohio State University. He is the former director of the Ohio State University Hospital's Special Coagulation Laboratory and its Hemophilia Center. He presently serves as chairman of the Central Investigational Review Board for the Cancer Therapeutics and Development branch of the National Cancer Institute and has served on the Peripheral and Central Nervous System Drug Advisory Committee and the Oncologic Drug Advisory Committee of the FDA. Dr. Smith serves as the co-chair of the Anticoagulation Task Force for the Presbyterian Hospital and its affiliates and chair of the Anticoagulation Working Group of the system-wide P and T committee.Dr. Smith is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Society for Scientific Exploration, The International Society of Thrombosis and Hemostasis, the American Medical Association and the American Society for Apheresis, and the American College of Chest Physicians. He is a Fellow of the American College of Physicians and the International Academy of Clinical and Applied Thrombosis and Hemostasis. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Acute Hepatic Porphyria (AHP), Shwartzman Phenomenon, Porphyria, and Venous Thromboembolism (VTE).

Radhakrishnan Ramchandren is a Hematologist in Pittsburgh, Pennsylvania. Dr. Ramchandren is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Mounzer Agha is a Hematologist in Pittsburgh, Pennsylvania. Dr. Agha is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Anastasios Raptis is a Hematologist in Pittsburgh, Pennsylvania. Dr. Raptis is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Robert Redner is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Redner is currently accepting new patients.

John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors. Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.

Sawa Ito, MD, PhD, specializes in hematology oncology and medical oncology and is board-certified by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Presbyterian, UPMC Magee-Womens Hospital, and UPMC Shadyside. Dr. Ito received her medical degree from Hokkaido University and completed residencies at Teine Keijinkai Hospital and the University of Pittsburgh School of Medicine, followed by a fellowship at the National Institutes of Health. Dr. Ito is rated as an Experienced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. Her top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.